# Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia.

> **NCT03216967** · PHASE4 · COMPLETED · sponsor: **University Hospital, Strasbourg, France** · enrollment: 130 (actual)

## Conditions studied

- BK Virus Nephropathy After Kidney Transplantation

## Interventions

- **DRUG:** everolimus

## Key facts

- **NCT ID:** NCT03216967
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-15
- **Primary completion:** 2024-08-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03216967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03216967, "Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03216967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*